SL-28 for advanced solid tumors that haven’t responded to treatment
Part of Cancer, Digestive system, Hormones & metabolism, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This trial tests a new drug, SL-28, for people with advanced solid tumors that haven’t responded to or cannot be treated with standard therapies. It aims to find a safe dose and see if the drug can help shrink or slow the growth of your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have an advanced solid tumor that cannot be removed by surgery.
- Standard treatments (like chemo, immunotherapy, or targeted therapy) should have stopped working, caused bad side effects, or you have chosen not to take them.
- You need to be in fairly good physical shape (able to take care of yourself and do light activities).
- Your kidneys, liver, and blood counts must be working well enough in the last blood tests.
- You should not have serious heart disease, uncontrolled infections, or other major health conditions that would make the trial unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial provides early access to an experimental drug called SL-28 for people with advanced solid tumors that have not responded to or have come back after standard treatments. The goal is to see if the drug can help control the cancer when other options have run out.
This trial tests a new drug called SLV-154 for people whose advanced cancer has not responded to standard treatments. The goal is to see if SLV-154 can shrink tumors or slow cancer growth.
This phase 1 trial tests a new drug called SLV-324 for people with solid tumors that have spread and are no longer responding to standard treatments. The goal is to see if the drug is safe and works against the cancer.
This early-phase study tests VLS-1488, a new cancer medicine, in people with advanced cancers that have limited treatment options. It may help by finding a safe dose and whether it can shrink or control tumors.
This trial tests a new drug called NBL-028 in people with advanced solid tumors that have a specific protein (CLDN6). It is for those who have already tried standard treatments. The goal is to see how safe and effective the drug is.
This trial is testing an experimental medication called BL-M08D1 for people with head and neck cancer that has come back or spread, as well as other types of solid tumors. The goal is to see if the drug is safe and effective.
Hear when a new Pancreas Cancer, Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.